CFTR Modulators: Does One Dose Fit All?

por van der Meer, Renske, Wilms, Erik B., Heijerman, Harry G.M.
Publicado 2021

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators

por Aalbers, Bente L., Bronsveld, Inez, Hofland, Regina W., Heijerman, Harry G. M.
Publicado 2021

The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort

por Oppelaar, Lisa M., Luijk, Bart, Heijerman, Harry G.M., De Valk, Harold W., van Meerkerk, Gerdien Belle-
Publicado 2023

The relation between psychological distress and medication adherence in lung transplant candidates and recipients: A cross‐sectional study

por Wessels‐Bakker, Marion J., van de Graaf, Eduard A., Kwakkel‐van Erp, Johanna M., Heijerman, Harry G., Cahn, Wiepke, Schappin, Renske
Publicado 2021

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis

por Terpstra, Lotte C., Altenburg, Josje, Bronsveld, Inez, de Kruif, Martijn D., Berk, Yvonne, Snijders, Dominic, Rozemeijer, Wouter, Heijerman, Harry G. M., Boersma, Wim G.
Publicado 2022

Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation

por Burghard, Marcella, Takken, Tim, Nap-van der Vlist, Merel M., Nijhof, Sanne L., van der Ent, C. Kors, Heijerman, Harry G.M., Hulzebos, H.J. Erik
Publicado 2022

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with...

por Muilwijk, Danya, van Paridon, Tessa J., van der Heijden, Doris C., Faber-Bisschop, Brenda M., Zomer-van Ommen, Domenique D., Heijerman, Harry G.M., van der Ent, Cornelis K.
Publicado 2023

Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough

por Meerburg, Jennifer J., Albasri, Mehdi, van der Wiel, Els C., Andrinopoulou, Eleni‐Rosalina, van der Eerden, Menno M., Majoor, Christof J., Arets, Hubertus G.M., Heijerman, Harry G.M., Tiddens, Harm A.W.M.
Publicado 2019

Pharmacokinetics and safety of tobramycin nebulization with the I‐neb and PARI‐LC Plus in children with cystic fibrosis: A randomized, crossover study

por van Velzen, Annelies J., Uges, Joris W.F., Heijerman, Harry G.M., Arets, Bert G.M., Nuijsink, Marianne, van der Wiel‐Kooij, Els C., van Maarseveen, Erik M., van Zanten, Gijsbert A., Pullens, Bas, Touw, Daan J., Janssens, Hettie M.
Publicado 2019

Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation

por Kristensen, Maartje I., de Winter-de Groot, Karin M., Berkers, Gitte, Chu, Mei Ling J. N., Arp, Kayleigh, Ghijsen, Sophie, Heijerman, Harry G. M., Arets, Hubertus G. M., Majoor, Christof J., Janssens, Hettie M., van der Meer, Renske, Bogaert, Debby, van der Ent, Cornelis K.
Publicado 2021

Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia

por Amatngalim, Gimano D, Rodenburg, Lisa W, Aalbers, Bente L, Raeven, Henriette HM, Aarts, Ellen M, Sarhane, Dounia, Spelier, Sacha, Lefferts, Juliet W, Silva, Iris AL, Nijenhuis, Wilco, Vrendenbarg, Sacha, Kruisselbrink, Evelien, Brunsveld, Jesse E, van Drunen, Cornelis M, Michel, Sabine, de Winter-de Groot, Karin M, Heijerman, Harry G, Kapitein, Lukas C, Amaral, Magarida D, van der Ent, Cornelis K, Beekman, Jeffrey M
Publicado 2022